STOCK TITAN

Cardinal Health expands home care business with two tuck-in acquisitions

(Neutral)
(Positive)

Cardinal Health (NYSE: CAH) announced definitive agreements to acquire AdaptHealth's Diabetes Health business and all of Strive Medical for a combined purchase price of approximately $360 million in cash, subject to working capital adjustments. The deals support Cardinal Health's at-Home Solutions growth strategy in diabetes management and urology.

According to Cardinal Health, AdaptHealth's Diabetes Health business serves more than 225,000 people annually via a centralized mail-order, direct-to-patient model, while Strive Medical serves more than 20,000 people annually in urology, wound care, ostomy and incontinence. Building on the earlier Advanced Diabetes Supply acquisition, Cardinal Health reports it has migrated all ADS volume to its at-Home Solutions network, onboarded nearly 500,000 new customers, and launched the ContinuCare Pathway digital referral program. The new transactions are subject to customary closing conditions, including regulatory approvals, and are expected to be accretive to non-GAAP EPS within 12 months after closing.

Loading...
Loading translation...

Positive

  • Two tuck-in acquisitions totaling approximately $360 million in cash
  • Targets collectively serve over 245,000 patients annually across diabetes and urology supplies
  • Prior ADS acquisition added nearly 500,000 new at-home customers
  • All ADS volume migrated to Cardinal Health's at-Home Solutions distribution network
  • New deals expected to be accretive to non-GAAP EPS in first 12 months post-close

Negative

  • Cardinal Health to deploy approximately $360 million of cash for the acquisitions
  • Closings depend on customary conditions and required regulatory approvals, introducing execution risk

News Market Reaction – CAH

+0.59%
+0.59% Session close to close

In the Jul 21 session, CAH gained 0.59%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Acquisition-tagged events averaged 0.34% across CAH's historical acquisition record. That history pl...
Analysis

Acquisition-tagged events averaged 0.34% across CAH's historical acquisition record. That history places the new expansion within an established pattern; customary approvals remain a risk, while the active S-3ASR is relevant financing context.

Key Figures

Transaction value: $360 million New customers: nearly 500,000 customers Diabetes Health patients: more than 225,000 people annually +2 more
5 metrics
Transaction value $360 million Combined cash consideration for two acquisitions
New customers nearly 500,000 customers Onboarded following the ADS acquisition
Diabetes Health patients more than 225,000 people annually AdaptHealth Diabetes Health business
Strive Medical patients more than 20,000 people annually Strive Medical customer reach
EPS accretion timing 12 months Expected non-GAAP EPS accretion following close

Previous Acquisition Reports

2 past events · Latest: Nov 03 (Positive)
Same Type Pattern 2 events
Date Event Sentiment 24h Move Catalyst
Nov 03 Solaris acquisition Positive -0.3% Cardinal completed Solaris Health acquisition, expanding its national urology physician platform.
Sep 20 ION acquisition Positive +1.0% Cardinal announced ION acquisition, adding community oncology practices and expected EPS accretion.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

CAH's acquisition-tagged history was mixed, with one reaction diverging and one aligning with the announcement's positive acquisition framing.

Key Terms

working capital adjustments, continuous glucose monitors, non-GAAP earnings per share, durable medical equipment
4 terms
working capital adjustments financial
"Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments."
An adjustment made after a business sale or valuation to reflect the target company’s short-term operating resources—things like inventory, customer invoices owed to the company, and bills the company must pay—so the buyer pays for the business as a running concern. Think of it like checking the gas and mileage when buying a used car and changing the price if the tank or wear is different than expected; investors care because it changes the final purchase price, affects ongoing cash available to run the business, and alters deal returns.
continuous glucose monitors medical
"delivers supplies like continuous glucose monitors to support the ongoing management of diabetes."
A continuous glucose monitor is a small wearable device with a sensor placed just under the skin that measures blood-sugar levels around the clock and sends those readings to a display or smartphone — like a fitness tracker for glucose. Investors care because adoption and repeat purchases of sensors and supplies create steady revenue, while clinical usefulness, pricing, insurance coverage and regulatory approval determine how fast and widely the devices sell.
non-GAAP earnings per share financial
"expected to be accretive to non-GAAP earnings per share in the first 12 months"
Non-GAAP earnings per share is a company’s reported profit per share after removing certain items that management considers one-time, unusual, or not part of regular operations, such as restructuring costs, stock-based compensation, or asset write-downs. Investors use it like an “adjusted score” to see what management believes is the company’s ongoing, core profitability, but because the adjustments vary between firms it should be compared carefully across companies.
durable medical equipment medical
"Strive Medical...is a leading national durable medical equipment (DME) provider"
Durable medical equipment (DME) includes long-lasting devices used to help people manage health conditions and improve mobility, such as wheelchairs, hospital beds, and oxygen machines. These items are designed to be reused and are often covered by health insurance. For investors, DME represents a steady market because demand remains consistent as populations age and healthcare needs grow.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy.

Cardinal Health Logo

Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ: AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments.

"These strategic transactions build on the synergies created by our recent investments in home care," said Jason Hollar, Chief Executive Officer, Cardinal Health. "As a natural extension of our at-Home Solutions growth strategy, they expand our enterprise-wide depth and breadth across important therapeutic categories like diabetes management and urology, further strengthening our leadership in a highly dynamic industry."

Both agreements enhance the framework established by Cardinal Health's most recent acquisition of Advanced Diabetes Supply (ADS). The company recently highlighted the progress of its at-Home Solutions business one year after its acquisition of ADS, including integration achievements that were realized ahead of plan. Since closing the original ADS transaction, the team successfully migrated all ADS volume onto the at-Home Solutions efficient and technology-enabled distribution network, onboarded nearly 500,000 new customers, and launched ContinuCare Pathway, a unique pharmacy-to-supplier digital referral pathway program.

"Our significant operational achievements in FY26 position us to continue building the country's leading platform to deliver simplified, innovative and high-quality care in the home, both organically and through acquisition," said Rob Schlissberg, President of Cardinal Health at-Home Solutions.

Layering these transactions on top of previous investments in the at-Home Solutions business also expands the company's ability to deliver high-quality service at scale. 

AdaptHealth's Diabetes Health business, which serves more than 225,000 people annually, operates primarily as a centralized, mail-order, direct-to-patient model that delivers supplies like continuous glucose monitors to support the ongoing management of diabetes.

Strive Medical serves more than 20,000 people annually as one of the nation's leading independent home medical supply providers specializing in urology, wound care, ostomy, and incontinence supplies, expanding Cardinal Health's enterprise-wide capabilities in this critical therapeutic area.  

These transactions are subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals, and are expected to be accretive to non-GAAP earnings per share in the first 12 months following close.  

Advisors
J.P. Morgan Securities LLC served as financial advisor to Cardinal Health on both acquisitions. Skadden, Arps, Slate, Meagher & Flom LLP and DLA Piper served as legal advisors to Cardinal Health on the acquisition of AdaptHealth's diabetes business. BakerHostetler LLP and DLA Piper LLP served as legal advisors to Cardinal Health on the acquisition of Strive Medical.

About Cardinal Health  

Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.

About AdaptHealth

AdaptHealth Corp. is a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies, and related services. Through its network of full-service medical equipment providers, AdaptHealth delivers tailored products and services designed to help patients manage chronic conditions and live independently in their homes. It serves beneficiaries of Medicare, Medicaid, and commercial insurance plans and reaches millions of patients annually.

About Strive Medical LLC

Strive Medical, an NMS Capital portfolio company, is a leading national durable medical equipment (DME) provider specializing in urology, incontinence, and wound care supplies delivered directly to patients. As an Accreditation Commission for Health Care (ACHC) accredited organization, Strive Medical manages the full insurance billing process – including Medicare, Medicaid, and over 5,000 private insurance plans – making access to essential supplies seamless for patients and referring providers alike. For more information, visit strivemedical.com

Contacts

Media: Cari Wildasinn, Cari.Wildasinn@cardinalhealth.com and (614) 757-8287

Investors: David Frost, David.Frost@cardinalhealth.com and (614) 553-4460

Cautions Concerning Forward-Looking Statements

This news release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook, and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include risks associated with the planned acquisitions addressed in this release, including the risk that we may not receive required regulatory approval or otherwise fail to complete one or both of the acquisitions and the risk that we may fail to realize the anticipated strategic and financial benefits of the acquisitions. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This news release reflects management's views as of July 20, 2026. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. Forward-looking statements are aspirational and not guarantees or promises that goals, targets or projections will be met, and no assurance can be given that any expectation, initiative or plan in this news release can or will be achieved or completed.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-expands-home-care-business-with-two-tuck-in-acquisitions-302829980.html

SOURCE Cardinal Health

FAQ

What did Cardinal Health (CAH) announce about new acquisitions in its at-home care business on July 20, 2026?

Cardinal Health announced definitive agreements to acquire AdaptHealth's Diabetes Health business and Strive Medical for about $360 million in cash. According to Cardinal Health, these tuck-in deals expand its at-Home Solutions platform in diabetes management, urology, wound care, ostomy, and incontinence supplies.

How much is Cardinal Health paying for AdaptHealth's Diabetes Health business and Strive Medical (CAH, AHCO)?

Cardinal Health plans to pay a combined purchase price of approximately $360 million in cash, subject to working capital adjustments. According to Cardinal Health, this total covers the acquisition of AdaptHealth's Diabetes Health business and the full ownership of Strive Medical.

How will the AdaptHealth Diabetes Health and Strive Medical acquisitions impact Cardinal Health’s (CAH) earnings?

Cardinal Health expects the transactions to be accretive to non-GAAP earnings per share in the first 12 months following closing. According to Cardinal Health, this anticipated EPS accretion reflects integration into its at-Home Solutions platform and expanded home-care capabilities.

What patient reach do the AdaptHealth Diabetes Health and Strive Medical businesses add for Cardinal Health (CAH)?

AdaptHealth's Diabetes Health business serves more than 225,000 people annually, and Strive Medical serves over 20,000. According to Cardinal Health, these acquisitions add large direct-to-patient supply operations in diabetes and urology-related categories to its at-home care offering.

How do these new deals build on Cardinal Health’s prior Advanced Diabetes Supply (ADS) acquisition?

Cardinal Health reports that after acquiring ADS, it migrated all ADS volume to its at-Home Solutions network and onboarded nearly 500,000 new customers. According to Cardinal Health, the new acquisitions further scale this home-care platform and enhance its diabetes and urology focus.

When are the Cardinal Health (CAH) acquisitions of AdaptHealth’s Diabetes Health business and Strive Medical expected to close?

Cardinal Health has not given a specific closing date; the deals remain subject to customary conditions and regulatory approvals. According to Cardinal Health, completion will occur after these requirements are satisfied, after which the company targets EPS accretion within 12 months.

What is the strategic rationale for Cardinal Health acquiring AdaptHealth’s Diabetes Health business and Strive Medical (CAH, AHCO)?

Cardinal Health states the acquisitions extend its at-Home Solutions growth strategy and deepen its presence in diabetes management and urology. According to Cardinal Health, they expand enterprise-wide capabilities and leverage its technology-enabled, direct-to-patient distribution model for home-based care.